Zepbound Savings Card & Coupons 2026: What Actually Cuts the Price

Are there free Zepbound samples or a trial program?

No — and it's worth saying plainly, because the phrase gets searched constantly and the sites that answer it vaguely are usually trying to sell you something else. Eli Lilly does not run a free-sample program, a trial voucher, or any mechanism that hands out real Zepbound medication at no cost, whether you're insured or not.

What does exist, and what some sites blur together with "free samples," is a starter kit: educational material about beginning treatment, injection technique, and what to expect. It's genuinely useful if you're new to a GLP-1 medication, but it isn't medication, and it isn't free product. If a website is offering you an actual free vial or pen with no prescription and no cost, that's the scam pattern covered further down this page, not a real Lilly channel.

Is there a real Zepbound coupon for 2026 — and how much does it cut the bill?

Yes, and it's the single biggest lever on this page for anyone it applies to. Lilly runs an official Zepbound Savings Card: enroll online, activate it, and use it at the pharmacy counter or through a LillyDirect prescription. Eligible patients pay as little as $25 for a one-, two-, or three-month fill, with the company's own contribution capped at $100, $200, or $300 a month depending on how much you fill at once, and a $1,300 ceiling for the calendar year. You get up to 13 fills annually, and the version live now expires December 31, 2026 — expect Lilly to roll out a fresh card around the new year, as it has every year since Zepbound launched.

Worth flagging if you compared this to an older article: the 2026 card is actually less generous than the 2025 version. The annual cap dropped from $1,950 to $1,300, and the monthly savings ceiling fell from $150 to $100. It's still the strongest deal on this page for anyone who qualifies — just don't be surprised if the numbers you remember from last year don't match this year's card.

Who actually qualifies for the Zepbound Savings Card — and who's excluded

The card has one real gate: commercial insurance that covers Zepbound as a benefit, even a partial one. A steep deductible or a prior-authorization hoop doesn't disqualify you — the existence of a covered benefit is what the card checks for.

• Qualifies: commercially insured, plan covers Zepbound (even with a copay or coinsurance), 18 or older, US or Puerto Rico resident.
• Excluded by federal rule: Medicare (any part), Medicare Advantage, Medigap, Medicaid, TRICARE, and VA or DoD coverage — even if it's secondary to a commercial plan.
• Also excluded: commercial plans that flatly don't cover Zepbound at all, since there's no underlying benefit for the coupon to discount.

That federal exclusion isn't Lilly being stingy — manufacturer copay coupons are barred from government health programs by law, to prevent the appearance of kickbacks. It's the same rule that keeps every drug-company coupon, not just this one, off Medicare and Medicaid claims.

No insurance, or the card just doesn't apply — LillyDirect's self-pay vials, dose by dose

For everyone the savings card leaves out — no coverage at all, or a plan that excludes Zepbound — LillyDirect is Lilly's own self-pay channel, and it's the next-best official price by a wide margin over retail. The trade-off that makes the lower price possible: you get single-dose vials, not the pre-filled pen, so you're drawing the dose yourself with a syringe rather than clicking a pen.

• 2.5mg starter dose: $299 a month.
• 5mg: $399 a month.
• 7.5mg through 15mg, the range most people land on long-term: $449 a month, flat across all four of those doses.

The rule to build a calendar reminder around: that pricing holds only if you refill within 45 days of your last delivery. Miss the window on a 7.5mg-or-higher dose and the price resets by dose rather than jumping to one flat number — $599 at 7.5mg, up to $1,049 at 15mg. On a maintenance dose, that's a difference worth setting a phone alarm for.

Does Medicare cover Zepbound now?

As of this writing, yes — for the first time, and it's new enough that a lot of pricing guides haven't caught up. Starting July 1, 2026 and running through the end of 2027, CMS's Medicare GLP-1 Bridge program lets eligible Part D beneficiaries fill the Zepbound KwikPen for a flat $50 monthly copay, one that doesn't count toward your deductible or out-of-pocket max. It only covers the KwikPen formulation — the single-dose vial and single-dose pen versions Lilly sells elsewhere aren't included in the Bridge.

Eligibility runs on BMI and related conditions rather than insurance type: a BMI of 35 or higher qualifies on its own, a BMI of 30 or higher qualifies alongside heart failure, uncontrolled hypertension, or stage 3a-or-worse chronic kidney disease, and a BMI of 27 or higher qualifies with pre-diabetes or a history of heart attack, stroke, or symptomatic peripheral artery disease. It's built for weight reduction specifically — if your prescription is really for type 2 diabetes, moderate-to-severe sleep apnea, or advanced liver disease, you go through standard Part D coverage instead, not the Bridge.

This is a separate program from the manufacturer savings card, and Medicare patients were already excluded from that card by federal rule — so the Bridge isn't a workaround, it's a genuinely new pathway that didn't exist a year ago.

Patient assistance for uninsured, low-income women — does Lilly Cares cover Zepbound?

Not currently, and this is the gap that trips up the most searches. Lilly Cares Foundation, the company's charitable assistance arm, provides a free 12-month supply of Mounjaro to uninsured patients with a documented type 2 diabetes prescription and household income at or below roughly 400% of the Federal Poverty Level. Zepbound is not on Lilly Cares' covered-medication list as of this check.

That's a real, meaningful program if you have a type 2 diabetes diagnosis — but it doesn't help if weight management, not diabetes, is why you're looking at this medication. If your income and insurance situation would otherwise qualify you, it's worth checking directly, since assistance formularies do get revisited, and worth asking your prescriber whether a Mounjaro prescription is genuinely appropriate on its own medical merits rather than as a substitute.

Does GoodRx or a retail coupon beat the official programs?

Worth a quick check, but temper expectations. GoodRx built its reputation on generic drugs, where it can cut a price by 80% or more — that reputation doesn't carry over here. Zepbound is still under patent, and Lilly's contracts with the pharmacy-benefit middlemen behind discount cards leave little room for a real cut. Recent pricing checks put GoodRx and SingleCare somewhere in the $950-to-$1,090-a-month range for Zepbound — a modest discount off full retail, not the kind of cut that competes with the savings card or LillyDirect.

You also can't stack it with anything. GoodRx is a cash-price coupon you use instead of insurance, not alongside it, and it can't be layered on top of the manufacturer savings card either. If your plan covers Zepbound at all, the savings card will beat GoodRx by a wide margin. Treat GoodRx as a price-check against LillyDirect, not a first move.

Red flags: sites promising free Zepbound samples or suspiciously cheap coupons

Eli Lilly has published its own warnings about counterfeit and gray-market tirzepatide, and the company has tested some of what's circulating online — finding bacterial contamination, impurities, and product that doesn't match the approved drug's chemical structure at all. A free-sample offer, or a coupon that undercuts LillyDirect's $299 floor, is the clearest signal something's off.

• No prescription required, or a prescription rubber-stamped without a real consultation.
• Payment requested by cryptocurrency, wire transfer, or gift card — a legitimate pharmacy bills insurance or a card.
• Shipping from outside the US, or a seller reaching out first through social media or a direct message.
• A price meaningfully below LillyDirect's official self-pay tiers, with no insurance or coupon involved.

The safe list is short: LillyDirect directly, or a licensed US pharmacy filling a real prescription. Everything on this page routes through one of those two.

The annual math: what each route actually costs you over a year

A monthly number flattens how differently these programs add up once you spread them across twelve months.

• Zepbound Savings Card (insured, $25/fill): roughly $300/year out of pocket, with Lilly covering up to $1,300/year of the rest.
• Medicare GLP-1 Bridge ($50/mo copay): about $600/year, through the program's scheduled end in December 2027.
• LillyDirect self-pay, 2.5mg starter: about $3,588/year.
• LillyDirect self-pay, 5mg: about $4,788/year.
• LillyDirect self-pay, 7.5-15mg maintenance, on-time refills: about $5,388/year.
• GoodRx/SingleCare (~$950-$1,090/mo, unconfirmed): roughly $11,400 to $13,080/year.
• Retail, nothing applied (~$1,059-$1,086/mo): roughly $12,708 to $13,032/year.
• Lilly Cares: $0/year for a 12-month supply — but Mounjaro only, not Zepbound.

The gap that actually matters: the savings card is worth something like $12,000 a year compared to paying retail, for anyone whose insurance qualifies them. GoodRx's real-world savings on this specific drug are modest by comparison — know which bracket you're in before assuming any single number is your answer.

Nothing here applies to you? The realistic next-cheapest route

Some women land outside every program on this page: insurance that excludes Zepbound outright, no type 2 diabetes diagnosis to unlock the Mounjaro coupon or Lilly Cares, and a BMI or income profile that doesn't fit the Medicare Bridge. If that's you, full retail isn't the honest next step.

It's also worth knowing that Zepbound and Mounjaro — same molecule, tirzepatide, different FDA-approved uses — run on two separate coupon programs with different rules, and a Mounjaro prescription written for weight loss generally won't unlock its card. If you're weighing whether a genuine diabetes diagnosis makes Mounjaro's pricing worth a conversation with your prescriber, the full Zepbound-vs-Mounjaro coupon breakdown and Mounjaro's cost page cover that split in more depth than makes sense to repeat here.

Compounded tirzepatide, sold through telehealth providers under a narrow individual-patient pathway, is currently the lowest-cost legitimate alternative for women outside every official program — running below LillyDirect's self-pay tiers for most providers, though it's pharmacy-mixed rather than an FDA-approved finished product, a real distinction to weigh against the savings.